TITLE

Residents' Research Day at the University of Alberta

AUTHOR(S)
Lewanczuk, Richard
PUB. DATE
August 1999
SOURCE
Clinical & Investigative Medicine;Aug99, Vol. 22 Issue 4, p161
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Features the abstracts that were presented at Residents' Research Day which was held at the University of Alberta in Edmonton on May 6, 1999. `Melanoma cell death induced by sphingosine and betulinic acid,' by Norman R. Wasel et al.; `Pseudomonas hot foot syndrome,' by Loretta Fiorillo et al.; `The role of radiation therapy in the management of acromegaly,' by R. Luongo and C. Chik.
ACCESSION #
2264444

 

Related Articles

  • AACE Releases New Clinical Practice Guidelines for Diagnosis & Treatment of Acromegaly.  // Biomedical Market Newsletter;8/12/2011, Vol. 21, p552 

    The article reports on the updated Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly released by the American Association of Clinical Endocrinologists (AACE). It says that the new guidelines provide the latest treatment options for Acromegaly, a medical...

  • Calcium Efflux as a Component of the Hypersensitive Response of Nicotiana benthamiana to Pseudomonas syringae. Lev G. Nemchinov; Lana Shabala; Sergey Shabala // Plant & Cell Physiology;Jan2008, Vol. 49 Issue 1, p40 

    Using a model plant Nicotiana benthamiana, we have demonstrated that initial calcium uptake in response to the HR (hypersensitive response)-causing pathogen Pseudomonas syringae pv syringae 61 is followed by net calcium efflux initiated at about 12 h after the bacterial challenge and sustained...

  • Octreotide enters the market against acromegaly. Cerrato, Paul L. // RN;Jan96, Vol. 59 Issue 1, p69 

    Reports that octreotide (Sandostatin) is commercially available for the treatment of acromegaly. Symptoms of acromegaly; Administration and dosage.

  • Hypoxia Stimulates Release of the Soluble Form of Fas Ligand That Inhibits Endothelial Cell Apoptosis. Mogi, Masaki; Fukuo, Keisuke; Jin Yang; Suhara, Toshimitsu; Ogihara, Toshio // Laboratory Investigation (00236837);Feb2001, Vol. 81 Issue 2, p177 

    Fas ligand (FasL), an apoptosis-inducing cytokine, is constitutively expressed on endothelial cells (EC). Here, we report that the soluble form of FasL (sFasL) is released from EC and inhibits hypoxia-induced EC apoptosis. For hypoxia experiments, hu

  • Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Letai, Anthony G. // Nature Reviews Cancer;Feb2008, Vol. 8 Issue 2, p121 

    Cancer cells survive despite violating rules of normal cellular behaviour that ordinarily provoke apoptosis. The blocks in apoptosis that keep cancer cells alive are therefore attractive candidates for targeted therapies. Recent studies have significantly increased our understanding of how...

  • RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice. Khandelwa, S.R.; Kavanagh, B.D.; Lin, P.-S.; Truong, Q.T.; Lu, J.; Abraham, D.J.; Schmidt-Ullrich, R.K. // British Journal of Cancer;2/15/99, Vol. 79 Issue 5/6, p814 

    Pre-clinical evaluation has demonstrated that 2-[4-(((3,5-dimethylanilino)carbonyl)methyl)phenoxy]-2-methylpropionic acid (RSR13) acts as an allosteric effector of haemoglobin (Hb). RSR13 binding to Hb results in decreased haemoglobin–oxygen (Hb–O2) affinity, improved tumour...

  • Will imaging of apoptosis play a role in clinical care? A tale of mice and men. Blankenberg, F. G.; Strauss, H. W. // Apoptosis;Feb2001, Vol. 6 Issue 1, p117 

    Programmed cell death (apoptosis) plays a role in the pathophysiology of many diseases and in the outcome of treatment. Apoptosis is the likely mechanism behind the cytoreductive effects of standard chemotherapeutic and radiation treatments, rejection of organ transplants, cellular damage in...

  • Expression and purification of human TAT-p53 fusion protein in Pichia pastoris and its influence on HepG2 cell apoptosis. Yan, Haowei; Liu, Nan; Zhao, Zhenghong; Zhang, Xinmin; Xu, Hao; Shao, Bing; Yan, Weiqun // Biotechnology Letters;Jul2012, Vol. 34 Issue 7, p1217 

    P53 is an attractive target in molecular cancer therapeutics because of its critical role in regulating cell cycle arrest and apoptosis. The limitations in the development of p53-based cancer therapeutic strategy include its inefficient transmission through cell membrane of tumor cells and low...

  • Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. Song Li; Baolu Wang; Yan Xu; Junjie Zhang // Molecular Cancer;2011, Vol. 10 Issue 1, p18 

    Background: Autotaxin (ATX) is a secreted glycoprotein with the lysophospholipase D (lysoPLD) activity to convert lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA), a bioactive lysophospholipid involved in diverse biological actions. ATX is highly expressed in some cancer cells and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics